Image

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Recruiting
40 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

Description

PD is a progressive neurodegenerative disorder which includes motor and non-motor (autonomic) symptoms, such as constipation. OMM has been shown to improve constipation symptoms in non-diseased subjects and cerebral palsy subjects. Constipation will be measured before, during, and after treatment by a constipation scoring system (Cleveland Criteria) to measure the severity of constipation and by the Bristol Stool Scale to measure colonic transit time. The study subjects' assessment of their constipation symptoms (PAC-SYM) and quality of life (PAC-QOL) will also be measured throughout the study.

Studies have also shown that there is a difference in the gut and oral bacterial flora of constipated versus healthy adults, so subjects will be given the option to provide weekly stool samples for analysis to track bacterial colonies and to observe for any flora changes over the study period. This will provide data to determine if bacterial colonies in stool are altered by OMM.

The study will require ten weekly on-site visits over the course of eleven weeks. For the first half of the study, surveys and optional stool tests will be performed without OMM treatment for four weeks to obtain baseline data. For the second half of the study, all subjects will receive OMM for four weeks along with surveys and optional stool microbial tests to obtain the experimental data.

Eligibility

Inclusion Criteria:

  • Medically diagnosed with Parkinson's disease
  • Medically diagnosed with constipation (according to Rome III criteria)
  • Be over 40 years old

Exclusion Criteria:

  • No diagnosis of Parkinson's disease
  • No diagnosis of constipation that satisfies Rome III criteria
  • Medically diagnosed with irritable bowel syndrome
  • Another diagnosed cause for chronic constipation
  • Currently pregnant
  • Have another diagnosed neurologic condition (excluding headache or migraine, headache, migraine, dysautonomia, depression or other mood disorders (unless severe or uncontrolled), dementia or cognitive changes (unless severe), diffuse lewy body dementia, REM sleep behavior disorder, normal pressure hydrocephalus, multiple system atrophy P and C types, progressive supranuclear palsy, vascular parkinsonism, corticobasal ganglionic degeneration, and drug induced parkinsonism)
  • Spinal cord abnormality or lesion
  • Cancer of the gastrointestinal tract, abdomen, or pelvis
  • Anemia that has not been evaluated
  • Unexplained weight loss, fever, night sweats, rectal bleeding, or black stools in past 2 months
  • Active hepatitis, infectious mononucleosis, or enlarged spleen
  • Abdominal aortic aneurysm
  • Congenital malformation of the gastrointestinal tract
  • Abdominal or pelvic surgery within the past 6 weeks
  • Unable or unwilling to receive OMT.
  • Unable or unwilling to rate one's own stools using a visual chart or to bring a picture of one's stool to each visit

Study details
    Parkinson's Disease
    Constipation

NCT02344485

New York Institute of Technology

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.